1800-272-662
Shopping Cart 0
countryflagAU
Login

ZEN Graphene Solutions Ltd

Healthcare US ZTEK

0.652USD
0.0031(0.48%)

Last update at 2026-03-10T20:00:00Z

Day Range

0.590.65
LowHigh

52 Week Range

0.971.75
LowHigh

Fundamentals

  • Previous Close 0.65
  • Market Cap112.36M
  • Volume83178
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-12.23388M
  • Revenue TTM0.03M
  • Revenue Per Share TTM-
  • Gross Profit TTM -0.85701M
  • Diluted EPS TTM-0.08

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Income before tax -14.41427M -12.02211M -3.86865M -1.54088M -2.42815M
Minority interest - - - - -
Net income -14.41427M -38.69405M -3.86865M -1.53435M -2.42815M
Selling general administrative 10.62M 10.25M 4.20M 1.65M 2.46M
Selling and marketing expenses 0.31M 0.28M 0.07M 0.09M 0.07M
Gross profit -0.85701M -0.27504M -0.12680M -0.02488M -0.00530M
Reconciled depreciation 0.54M 0.61M 0.13M 0.02M 0.00530M
Ebit -14.14954M -11.95834M -3.98491M -1.67788M -2.46846M
Ebitda -13.60984M -11.34363M -3.85811M -1.56210M -2.46316M
Depreciation and amortization 0.54M 0.61M 0.13M 0.12M 0.00530M
Non operating income net other - - - - -
Operating income -14.51659M -12.56267M -3.98491M -1.67788M -2.46846M
Other operating expenses 14.73M 12.32M 3.98M 1.59M 2.47M
Interest expense 0.12M 0.06M 0.06M 0.00000M 0.00000M
Tax provision - - - - -
Interest income 0.51M 0.02M 0.00646M 0.00653M 0.02M
Net interest income 0.38M -0.04318M 0.00646M 0.00653M 0.02M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.12M 26.74M -0.00646M -0.00653M 0.04M
Total revenue 0.07M 0.34M 0.34M 0.00000M 0.00000M
Total operating expenses 14.73M 12.32M 3.98M 1.59M 2.47M
Cost of revenue 0.93M 0.61M 0.13M 0.02M 0.00530M
Total other income expense net -0.14612M 0.00188M 0.11M 0.14M 0.02M
Discontinued operations - -26.67194M -26.67194M -26.67194M -26.67194M
Net income from continuing ops -14.41427M -12.02211M -3.86865M -1.54088M -2.42815M
Net income applicable to common shares - -38.69405M -3.86865M -1.54088M -2.42815M
Preferred stock and other adjustments - - - - -
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Total assets 33.29M 37.98M 30.25M 26.24M 25.54M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 1.19M 1.01M 0.17M 0.19M 0.03M
Total liab 2.90M 3.44M 2.79M 0.53M 0.65M
Total stockholder equity 30.38M 34.55M 27.46M 25.71M 24.90M
Deferred long term liab - - - - -
Other current liab 1.51M 1.26M 2.01M 0.14M 0.03M
Common stock 85.75M 85.49M 43.80M 40.21M 38.31M
Capital stock 85.75M 85.49M 43.80M 40.21M 38.31M
Retained earnings -66.19831M -59.17925M -20.48983M -16.90418M -16.31167M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 10.36M 26.68M 3.09M 0.81M 1.22M
Cash and equivalents - - - - -
Total current liabilities 2.42M 2.30M 2.51M 0.53M 0.65M
Current deferred revenue -1.12734M -1.10025M 0.03M -0.12245M -
Net debt -8.74512M -24.44413M -2.68722M -0.80595M -1.22149M
Short term debt 1.13M 1.10M 0.12M 0.12M -
Short long term debt 1.00M 0.95M - - -
Short long term debt total 1.61M 2.23M 0.40M 0.40M -
Other stockholder equity -19.55609M 8.23M -23.31213M -23.30756M -21.99610M
Property plant equipment - 6.03M 26.86M 25.16M 24.08M
Total current assets 17.95M 31.96M 3.39M 1.07M 1.47M
Long term investments - - - - -
Net tangible assets - 34.55M 27.46M 25.71M 24.90M
Short term investments - - - - -
Net receivables 3.55M 3.61M 0.12M 0.08M 0.22M
Long term debt - 1.00M - - -
Inventory 2.85M 0.67M 0.67M - -
Accounts payable 0.91M 1.04M 0.35M 0.39M 0.62M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - 1.75M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other -15.33587M - -26.86495M -25.16459M -24.07535M
Deferred long term asset charges - - - - -
Non current assets total 15.34M 6.03M 26.86M 25.16M 24.08M
Capital lease obligations 0.61M 0.28M 0.40M - -
Long term debt total - - - - -
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Investments -2.30658M -7.25261M -1.23324M -1.23514M -1.73709M
Change to liabilities -0.01738M 0.83M 0.06M -0.07129M 0.55M
Total cashflows from investing activities - -7.25261M -1.23324M -1.23514M -1.73709M
Net borrowings - -0.12245M -0.07390M -0.07390M -0.07390M
Total cash from financing activities -1.05424M 38.82M 5.31M 2.18M 4.05M
Change to operating activities -0.18161M -0.98552M 0.02M -0.16270M 0.02M
Net income -14.41427M -12.02211M -3.86865M -1.54088M -2.42815M
Change in cash -16.31768M 23.58M 2.29M -0.41554M 1.12M
Begin period cash flow 26.68M 3.09M 0.81M 1.22M 0.10M
End period cash flow 10.36M 26.68M 3.09M 0.81M 1.22M
Total cash from operating activities -12.95687M -7.98887M -1.79468M -1.35639M -1.18355M
Issuance of capital stock 0.00000M 35.34M 2.05M 2.26M 4.30M
Depreciation 0.54M 0.61M 0.13M 0.02M 0.00530M
Other cashflows from investing activities - -0.31670M 0.13M 0.37M 0.37M
Dividends paid - - - - -
Change to inventory -2.18350M -0.66557M -0.66557M -0.66557M -0.66557M
Change to account receivables -0.01284M -0.53682M -0.04181M 0.14M -0.18919M
Sale purchase of stock - - - - -
Other cashflows from financing activities 0.05M 3.60M 3.34M -0.08402M -0.25904M
Change to netincome - 31.45M 1.91M 0.25M 0.86M
Capital expenditures 2.27M 3.99M 0.25M 0.10M 0.00344M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -2.39533M -1.35642M 0.04M -0.09439M 0.38M
Stock based compensation 3.20M 4.73M 2.02M 0.29M 0.89M
Other non cash items 0.92M 0.05M -0.10980M -0.03957M 1.24M
Free cash flow -15.22980M -11.97478M -2.04896M -1.45960M -1.18698M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ZTEK
ZEN Graphene Solutions Ltd		 0.0031 0.48% 0.65 - - 3616.03 7.31 2438.99 -10.4053
ISRG
Intuitive Surgical Inc		 -7.71 1.56% 485.85 73.05 61.73 19.15 10.25 18.41 59.92
ESLOY
Essilor International SA		 -0.25 0.20% 122.50 35.39 24.81 3.63 2.20 4.00 16.25
ESLOF
EssilorLuxottica Société anonyme		 4.90 2.00% 249.71 35.71 25.13 3.62 2.23 4.00 16.25
BDX
Becton Dickinson and Company		 -1.58 0.95% 163.88 37.72 15.92 3.25 2.49 4.08 17.10

Reports Covered

Stock Research & News

View All

Profile

Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops graphene oxide synthesis and graphene synthesis. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Guelph, Canada.

ZEN Graphene Solutions Ltd

24 Corporate Court, Guelph, ON, Canada, N1G 5G5

Key Executives

Name Title Year Born
Dr. Francis Dube B.Sc. Exec. Chairman NA
Mr. Gregory Fenton C.F.A. CEO & Director NA
Mr. Brian Bosse B.A., C.F.A. COO & Director 1973
Ms. Wendy Ford CA, CPA Chief Financial Officer NA
Dr. Colin van der Kuur B.Sc., DMIN VP of Science & Research NA
Mr. Ryan Shacklock VP of Strategy, Bus. Devel. & Investor Relations NA
Dr. Francis Dube B.Sc. COO & Director NA
Dr. Colin van der Kuur B.Sc., DMIN Chief Science Officer NA
Mr. Ryan Shacklock Senior Vice President of Strategy & Business Development NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.